Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease-antibiotic use in the history does not play a significant role

被引:40
|
作者
Prónai, L [1 ]
Schandl, L
Orosz, Z
Magyar, P
Tulassay, Z
机构
[1] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Med 2,Gastroenterol Res Unit, Budapest, Hungary
[2] Semmelweis Univ, Dept Pulmonol, H-1088 Budapest, Hungary
关键词
Helicobacter pylori; inflammatory bowel disease; Crohn's disease; ulcerative colitis; chronic obstructive pulmonary disease;
D O I
10.1111/j.1083-4389.2004.00223.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Patients with inflammatory bowel disease have lower prevalence of Helicobacter pylori infection, but the exact reason for this is not yet clear. Aim. To examine whether the antibiotics frequently used in inflammatory bowel disease are responsible for the lower prevalence of H. pylori infection. Patients with chronic obstructive pulmonary disease on prolonged previous antibiotic therapy were used for comparison. Methods. Presence/absence of H. pylori infection was detected by a C-13-urea breath test in 133 patients with inflammatory bowel disease (82 ulcerative colitis, and 51 Crohn's disease) and compared with that of 135 patients with chronic obstructive pulmonary disease and with two age-matched control groups (200 patients each). Primary disease location, duration of disease and detailed analysis of previous and current medication (dose and duration of antibiotics, steroids, 5-aminosalicylic acid) were analysed in each cases. Results. Seventeen of the 133 patients with inflammatory bowel disease [12.2% (10/82) of ulcerative colitis and 13.7% (7/51) of Crohn's disease] and 90/135 patients with chronic obstructive pulmonary disease (66.7%) were positive for H. pylori. A total of 78/200 (39%) for the inflammatory-bowel-discase-group-matched controls and 110/210 (55%) for the chronic-obstructive-pulmonary-disease-matched controls were positive for H. pylori. The history of any antibiotic or steroid therapy had no influence on H. pylori status of patients with inflammatory bowel disease. Conclusion. The prevalence of H. pylori compared to the age-matched controls is significantly lower in patients with inflammatory bowel disease but not in those with chronic obstructive pulmonary disease. Antibiotic use is not responsible for the lower prevalence of H. pylori infection in patients with inflammatory bowel disease.
引用
收藏
页码:278 / 283
页数:6
相关论文
共 50 条
  • [41] Prevalence and role of Helicobacter pylori infection in portal hypertensive gastropathy and hepatic encephalopathy of patients with chronic liver disease
    Gisbert, JP
    Moreno-Otero, R
    Pajares, JM
    HEPATOLOGY, 2002, 36 (04) : 508A - 508A
  • [42] Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease
    Smith, JA
    Redman, P
    Woodhead, MA
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (04) : 835 - 838
  • [43] Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease
    Shinzaki, Shinichiro
    Fujii, Toshimitsu
    Bamba, Shigeki
    Ogawa, Maiko
    Kobayashi, Taku
    Oshita, Masahide
    Tanaka, Hiroki
    Ozeki, Keiji
    Takahashi, Sakuma
    Kitamoto, Hiroki
    Kani, Kazuhito
    Nanjo, Sohachi
    Sugaya, Takeshi
    Sakakibara, Yuko
    Inokuchi, Toshihiro
    Kakimoto, Kazuki
    Yamada, Akihiro
    Yasuhara, Hisae
    Yokoyama, Yoko
    Yoshino, Takuya
    Matsui, Akira
    Nakamura, Misald
    Tomizawa, Taku
    Sakemi, Ryosuke
    Kamata, Noriko
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2018, 16 (04) : 609 - 618
  • [44] Association of Helicobacter pylori infection with chronic obstructive pulmonary disease and chronic bronchitis: a meta-analysis of 16 studies
    Wang, Feng
    Liu, Juan
    Zhang, Yun
    Lei, Ping
    INFECTIOUS DISEASES, 2015, 47 (09) : 597 - 603
  • [45] Does bacterial colonization play a role in acute respiratory failure in chronic obstructive pulmonary disease?
    Conrad, C
    CRITICAL CARE MEDICINE, 2005, 33 (09) : 2130 - 2131
  • [46] Increased risk of chronic obstructive pulmonary disease among patients with Helicobacter pylori infection: a population-based cohort study
    Peng, Yi-Hao
    Chen, Cheng-Kuo
    Su, Ching-Hua
    Liao, Wei-Chih
    Muo, Chih-Hsin
    Hsia, Te-Chun
    Sung, Fung-Chang
    Lai, Chih-Ho
    Kao, Chia-Hung
    CLINICAL RESPIRATORY JOURNAL, 2017, 11 (05): : 558 - 565
  • [47] Role of Helicobacter pylori infection in peptic ulcer in patients with chronic liver disease.
    Gisbert, JP
    Moreno-Otero, R
    Pajares, JM
    HEPATOLOGY, 2002, 36 (04) : 518A - 518A
  • [48] Chronic narcotic use in inflammatory bowel disease patients: Prevalence and clinical characteristics
    Edwards, JT
    Radford-Smith, GL
    Florin, THJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) : 1235 - 1238
  • [49] Role of comorbidities in acquiring pulmonary fungal infection in chronic obstructive pulmonary disease patients
    Ashraf Z. Mohamed
    Ahmad M. Moharrm
    Maha K. Ghanem
    Hoda A. Makhlouf
    Ebtesam M. El-Gezawy
    Sahar F. Youssif
    Egyptian Journal of Bronchology, 2016, 10 (3) : 243 - 250
  • [50] Prevalence and outcome of acute pulmonary embolism in hospitalized patients with a history of inflammatory bowel disease
    Iourinets, Julia
    Sawalski, Cathryn
    Desai, Parth
    Sutherland, David
    Shah, Parth
    Bruno, Elizabeth
    Arora, Punit
    Malik, Muhammad
    Patel, Axat
    Akhtar, Tauseef
    Fareed, Jawed
    Brailovsky, Yevgeniy
    Naik, Amar
    Darki, Amir
    THROMBOSIS RESEARCH, 2024, 239